Both in Pharmaceuticals
Vistagen Therapeutics vs Moleculin Biotech
Over the past year VTGN returned −94.7% and MBRX returned −96.5%; their daily moves had a correlation of 0.12.
VTGN −94.7% MBRX −96.5%Growth of $1, one year, split-adjusted
| Metric | VTGN | MBRX |
|---|---|---|
| Price | $0.2148 | $0.4352 |
| Market cap | $9.5M | $8.9M |
| Today | −5.21% | +5.15% |
| 1 month | −11.7% | −43.9% |
| 6 months | −64.2% | −82.5% |
| Year to date | −67.5% | −86.9% |
| 1 year | −94.7% | −96.3% |
| Revenue growth (YoY) | +504.9% | — |
| Gross margin | 100.0% | — |
| Net margin | −882.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.8× | — |
| Net cash | $31.7M | $7.3M |
| Dividend yield | — | — |
| Volatility (60d) | 114.0% | 249.6% |
| Short % of float | 8.7% | 1.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).